These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19714748)

  • 41. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study.
    Erichsen R; Baron JA; Stoffel EM; Laurberg S; Sandler RS; Sørensen HT
    Am J Gastroenterol; 2013 Aug; 108(8):1332-40. PubMed ID: 23774154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.
    Axelrad J; Kriplani A; Ozbek U; Harpaz N; Colombel JF; Itzkowitz S; Holcombe RF; Ang C
    Clin Colorectal Cancer; 2017 Sep; 16(3):e205-e210. PubMed ID: 27742264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia.
    van Schaik FD; ten Kate FJ; Offerhaus GJ; Schipper ME; Vleggaar FP; van der Woude CJ; Stokkers PC; de Jong DJ; Hommes DW; van Bodegraven AA; Siersema PD; Oldenburg B;
    Inflamm Bowel Dis; 2011 May; 17(5):1108-16. PubMed ID: 20824815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival in Danish patients with breast cancer and inflammatory bowel disease: a nationwide cohort study.
    Søgaard KK; Cronin-Fenton DP; Pedersen L; Sørensen HT; Lash TL
    Inflamm Bowel Dis; 2008 Apr; 14(4):519-25. PubMed ID: 18069672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
    Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
    Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The epidemiology of inflammatory bowel disease.
    Burisch J; Munkholm P
    Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
    Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
    Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
    Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F;
    Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors of colorectal cancer in inflammatory bowel disease.
    Bansal P; Sonnenberg A
    Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association Between Inflammatory Bowel Disease and Colorectal Cancer Stage of Disease and Survival.
    Taylor CC; Millien VO; Hou JK; Massarweh NN
    J Surg Res; 2020 Mar; 247():77-85. PubMed ID: 31767275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome of "indefinite for dysplasia" in inflammatory bowel disease: correlation with DNA flow cytometry and other risk factors of colorectal cancer.
    Choi WT; Rabinovitch PS; Wang D; Westerhoff M
    Hum Pathol; 2015 Jul; 46(7):939-47. PubMed ID: 25962315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study.
    Kim HJ; Hann HJ; Hong SN; Kim KH; Ahn IM; Song JY; Lee SH; Ahn HS
    Inflamm Bowel Dis; 2015 Mar; 21(3):623-30. PubMed ID: 25647154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease.
    Ananthakrishnan AN; McGinley EL; Saeian K; Binion DG
    Inflamm Bowel Dis; 2011 Apr; 17(4):976-83. PubMed ID: 20824818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.
    Gordillo J; Cabré E; Garcia-Planella E; Ricart E; Ber-Nieto Y; Márquez L; Rodríguez-Moranta F; Ponferrada Á; Vera I; Gisbert JP; Barrio J; Esteve M; Merino O; Muñoz F; Domènech E;
    J Crohns Colitis; 2015 Dec; 9(12):1063-70. PubMed ID: 26351379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Total and cancer mortality in a cohort of ulcerative colitis and Crohn's disease patients: The Florence inflammatory bowel disease study, 1978-2010.
    Caini S; Bagnoli S; Palli D; Saieva C; Ceroti M; Bendinelli B; Assedi M; Masala G
    Dig Liver Dis; 2016 Oct; 48(10):1162-7. PubMed ID: 27481588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
    World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.